Lv3
250 积分 2025-06-10 加入
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
7天前
已完结
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
7天前
已完结
Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
13天前
已完结
Pegozafermin for NASH — A Sprint to Start a Marathon
13天前
已完结
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
13天前
已完结
Microenvironment-responsive nano-bioconjugated vesicles for the multi-pronged treatment of liver fibrosis
2个月前
已完结
Integrin‐Enriched Membrane Nanocarrier for the Specific Delivery of RGD‐modified Relaxin Analog to Inhibit Pancreatic Cancer Liver Metastasis through Reversing Hepatic Stellate Cell Activation
2个月前
已完结
Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis
2个月前
已完结
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis
2个月前
已完结
Molecular Self-Assembly of Bioorthogonal Aptamer-Prodrug Conjugate Micelles for Hydrogen Peroxide and pH-Independent Cancer Chemodynamic Therapy
2个月前
已完结
皖公网安备34019202002308
